GOT GUTS GOT SCIENCE - G-NiiB GENIEBIOME

Our platform technologies are driving new solutions for early disease detection

Discovery Platform

G-NiiB GenieBiome holds a comprehensive and unique databank for unlimited microbiome discoveries

1. Comprehensive clinical samples with metadata

Over 8,000 consistently analysed stool samples with over 1000 longitudinal metadata points per sample in health and diseases.

2. Advanced bioinformatic and AI-driven analysis

Deep metagenomic analysis coupled with machine-learning models to identify species, strains, genes and functional pathways across eight common diseases to inform product development

3. Discoveries of disease-specific and highly accurate microbial signatures

Identify reliable signals by combining in-house and publicly profiled signatures to achieve the most systemically consistent microbial taxonomy and functions

4. Integrative analysis to dissecting complex host-microbe relationships

Extensive metadata including medical history, drugs, diet and lifestyle enables robust insights into identification of truly health- or disease-promoting associated species

5. Partnership with world-leading R & D Centers

G-NiiB GenieBiome’s Discovery Platform continues to develop close partnership with the Microbiota-I Center (MaGIC) to expand databank for data-driven discovery of product opportunities

Diagnostic platform

“Our proprietary microbial biomarkers are non-invasive, biologically relevant, and disease-specific.”

G-NiiB GenieBiome’s biomarker discovery platform utilizes in-depth metagenomic analysis of large human microbial datasets and in-house proprietary machine-learning approaches to identify microbiome signatures specific to different human diseases with high accuracy

1. Advanced sequencing and proprietary algorithms

G-NiiB GenieBiome’s core diagnostic technology includes metagenomic-sequencing derived-microbial signals transformed into proprietary algorithms to predict risk of diseases

2. At-home stool sample collection

Simple sampling method accurately with preservatives that maintain quality of microbial community profile at room temperature to facilitate convenient storage and transport

3. Development of PCR-based technologies for disease risk prediction

Transforming metagenomic sequencing microbial signals into targeted-PCR approaches and optimization of PCR technologies for highest accuracy

4. Discovery, validation and real-life testing

G-NiiB GenieBiome’s patented core PCR and metagenomics technology are extensively validated and demonstrates unparalleled performance in discovery, validation and real-life settings. Some of these technologies will be applied in clinical trials for regulatory approval as first-in-class IVD diagnostics

“G-NiiB GenieBiome’s leading technology in modifying the microbiome is driving health transformation for many human diseases”

Strategic Partners

Featured in

Global Publications & Awards

Education Articles

Bacterial metabolism center stage in the Light Lab

While a postdoc at UC Berkeley, Dr. Light's work illuminated the role of flavin-type extracellular electron transfer in driving energy metabolism in Gram-positive bacteria. His earlier research has looked…

Microbiome

2022-06-09